Five Prime Therapeutics Priced, Nasdaq: FPRX
Developing protein therapeutics for cancers and autoimmune diseases.
Industry: Health Care
First Day Return: +0.6%
Industry: Health Care
FPRX
Developing protein therapeutics for cancers and autoimmune diseases.
| IPO Data | |
|---|---|
| IPO File Date | 07/26/2013 |
| Offer Price | $13.00 |
| Price Range $12.00 - $14.00 | |
| Offer Shares (mm) | 4.8 |
| Deal Size ($mm) | $62 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 09/17/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $62 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | South San Francisco, CA, United States |
| Founded | 2001 |
| Employees at IPO | 108 |
| Website www.fiveprime.com | |
IPO News for Five Prime Therapeutics
Five Prime Therapeutics (FPRX) Performance
